PDE5 inhibitors have previously been shown to activate the cGMP/PKG/CREB signaling pathway, resulting in enhanced neuronal cell survival and improved memory functions in transgenic AD mouse models [6, 9, 36]. Here, PDE5A is linked to Alzheimer disease.